Orbicular Pharmaceutical Technologies Pvt. Ltd. is a pharmaceutical company that develops niche and complex pharmaceutical dosage forms for licensing to our global partners. Our focus is on technology barrier, limited competition products for the global markets with primary aim on the US market. The company ambitious plan is to execute the unique differentiated domain growth strategy C I-TOP SPIN Strategy for both Regulated and Emerging Markets. C I-TOP SPIN basically refers to Complex Injectables, Topicals, Ophthalmic, Parenteral, Nasal Sprays and Inhalations which characterizes a product domain that is complex, has entry barriers and a lucrative business domain. We partner with major national and international companies looking for advanced development solutions for synergistic value creation . We have comprehensive State of the Art Research Infrastructure measuring 60,000 plus sq.ft for end to end delivery capabilities across product design, characterisation, package design, scale-up, analytics, stability and quality assurance. We specialize in establishing micro-structural similarity (Q3) of dosage forms for seeking clinical waiver approach as a regulatory strategy. We have the complete bandwidth of related functional capabilities viz sourcing, intellectual property, clinical and PK, regulatory, packaging, technology transfer and quality assurance. We partner with global well reputed contract manufacturing organisations with excellent regulatory credentials to cover the regulatory submission, product approval and support product commercialisation process. ALEOR Dermaceuticals Ltd is our Joint Venture with Alembic Pharmaceuticals for the dermatological products across global markets.